Terug
Dagbereik
€ 113,31
€ 117,11
52-Weeksbereik
€ 113,31
€ 172,23
Volume
4.557.901
50D / 200D Gem.
€ 124,41
/
€ 138,35
Vorige Slotkoers
€ 115,23
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 19,1 | 0,3 |
| P/B | 15,3 | 2,9 |
| ROE % | 66,0 | 3,7 |
| Net Margin % | 28,2 | 3,8 |
| Rev Growth 5Y % | 5,0 | 10,0 |
| D/E | 2,9 | 0,2 |
Koersdoel Analisten
Hold
€ 143,86
+24.1%
Low: € 135,00
High: € 160,00
Forward K/W
16,4
Forward WPA
€ 7,01
WPA Groei (sch.)
+0,0%
Omzet Sch.
9,9 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 9,27
€ 9,10 – € 9,46
|
12 B | 1 |
| FY2029 |
€ 8,69
€ 8,54 – € 8,88
|
11 B | 1 |
| FY2028 |
€ 8,16
€ 7,75 – € 8,40
|
11 B | 5 |
Belangrijkste Punten
Revenue grew 5,04% annually over 5 years — modest growth
ROE of 65,99% indicates high profitability
Net margin of 28,23% shows strong profitability
Debt/Equity of 2,85 — high leverage
Generating 2,28B in free cash flow
Cash machine — converts 85,41% of earnings into free cash flow
Groei
Revenue Growth (5Y)
5,04%
Revenue (1Y)2,28%
Earnings (1Y)7,52%
FCF Growth (3Y)18,68%
Kwaliteit
Return on Equity
65,99%
ROIC21,04%
Net Margin28,23%
Op. Margin38,00%
Veiligheid
Debt / Equity
2,85
Current Ratio3,03
Interest Coverage14,80
Waardering
P/E Ratio
19,11
P/B Ratio15,34
EV/EBITDA16,20
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,28% | Revenue Growth (3Y) | 5,26% |
| Earnings Growth (1Y) | 7,52% | Earnings Growth (3Y) | 6,79% |
| Revenue Growth (5Y) | 5,04% | Earnings Growth (5Y) | 7,03% |
| Profitability | |||
| Revenue (TTM) | 9,47B | Net Income (TTM) | 2,67B |
| ROE | 65,99% | ROA | 17,28% |
| Gross Margin | 70,49% | Operating Margin | 38,00% |
| Net Margin | 28,23% | Free Cash Flow (TTM) | 2,28B |
| ROIC | 21,04% | FCF Growth (3Y) | 18,68% |
| Safety | |||
| Debt / Equity | 2,85 | Current Ratio | 3,03 |
| Interest Coverage | 14,80 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 19,11 | P/B Ratio | 15,34 |
| P/S Ratio | 5,40 | PEG Ratio | 2,04 |
| EV/EBITDA | 16,20 | Dividend Yield | 0,02% |
| Market Cap | 51,09B | Enterprise Value | 58,27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9,47B | 9,26B | 8,54B | 8,08B | 7,78B |
| Net Income | 2,67B | 2,49B | 2,34B | 2,11B | 2,04B |
| EPS (Diluted) | 6,02 | 5,47 | 5,07 | 4,49 | 4,27 |
| Gross Profit | 6,67B | 6,40B | 5,83B | 5,48B | 5,31B |
| Operating Income | 3,60B | 3,39B | 3,07B | 2,93B | 2,80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 15,47B | 14,24B | 14,29B | 14,93B | 13,90B |
| Total Liabilities | 12,14B | 9,47B | 9,30B | 10,52B | 9,36B |
| Shareholders' Equity | 3,33B | 4,77B | 5,00B | 4,41B | 4,54B |
| Total Debt | 9,49B | 6,74B | 6,76B | 8,09B | 6,74B |
| Cash & Equivalents | 2,31B | 1,99B | 2,04B | 3,58B | 3,48B |
| Current Assets | 6,77B | 5,99B | 6,34B | 7,51B | 6,93B |
| Current Liabilities | 2,24B | 3,41B | 1,89B | 3,17B | 1,80B |